Posts in tag

A*STAR


A test kit that can accurately identify SARS-CoV-2 antibodies in 15 minutes and employs a lateral flow format, similar to those used in home pregnancy tests, has been co-developed between A*STAR and diagnostics company MP Biomedicals. Serological test kits are especially important for contact-tracing purposes given that there are large numbers of asymptomatic COVID-19 cases …

As Singapore presses on in its fight against COVID-19, the use of face masks have become an integral part of daily lives to complement social distancing and personal hygiene practices. Singapore has been ramping up its masks production capabilities since experiments have shown that wearing a mask helps to prevent the spread of droplets that may carry …

A long-term research collaboration between A*STAR’s Genome Institute of Singapore (GIS) and the National University of Singapore (NUS) has successfully created first-in-class human liver organoids that capture both the functional and structural features of the organ. Notably, the advanced liver organoids are able to replicate structural changes that occur during liver injuries induced by drugs …

A team of scientists from the Agency for Science, Technology and Research’s (A*STAR) Genome Institute of Singapore (GIS) and the National University of Singapore (NUS) Yong Loo Lin School of Medicine has identified the microbial factors underlying the response of the gut microbiome to antibiotic treatment. The study discovered a small set of gut bacteria …

SGInnovate has launched Deep Tech for Good, a new initiative that seeks to accelerate the development and use of artificial intelligence (AI) and other frontier technologies to improve the human condition and drive sustainable development across different markets, according to an announcement. The initiative was launched at a virtual event with an international line-up of …

Duke-NUS Medical School (Duke-NUS), a research intensive graduate-entry medical school, GenScript Biotech Corporation (“GenScript”), a leading global biotechnology company, and the Diagnostics Development Hub (DxD) at Singapore’s Agency for Science, Technology and Research (A*STAR), today announced an exclusive agreement to co-develop and manufacture a unique serological coronavirus (COVID-19) detection system known as the surrogate virus …

A*STAR scientists, together with SingHealth doctors from the SGH Department of Infectious Diseases; and the Department of Respiratory and Critical Care Medicine; designed an experiment to show the importance of wearing a mask in helping to prevent the spread of viruses. The experiment showed that when the subject coughed without wearing a mask, respiratory droplets …

Since the Severe Acute Respiratory Syndrome (SARS) outbreak in 2003, Singapore is now better prepared to respond to the COVID-19 pandemic. In terms of R&D, Singapore has placed emphasis on a multi-disciplinary and collaborative approach to research on infectious diseases. This spans across A*STAR, the Institutes of Higher Learning such as NUS, NTU, Duke-NUS, and …

Close collaboration between scientists and the public health community have enabled the Fortitude Kit 2.0 diagnostic to be quickly developed and deployed in Singapore hospitals to detect the SARS-CoV-2 virus that causes COVID-19. From February, Fortitude Kit 2.0 has been in routine use in six public hospitals, and four private hospitals in Singapore. Currently, it …

The Agency for Science, Technology and Research (A*STAR), and Tan Tock Seng Hospital (TTSH), Singapore, have successfully developed a test kit which can detect the presence of the SARS-CoV-2 virus which causes COVID-19, quickly and with high accuracy. Called Fortitude Kit 2.0, the test was co-developed with, and validated by TTSH. It is the first …